HRT FINANCIAL LP

Position in MRNA — Moderna, Inc.

CIK 1475597 NEW YORK, NY

Position in MRNA

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$18,715,786

+$4,979,857 QoQ

Shares Held

368,421

-30.7% QoQ

Ownership

0.093%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $416,760,191 across 198 Biotechnology names. MRNA ranks #5 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	128,633	$42,560,800
2	IBRX	ImmunityBio, Inc.	3,925,446	$30,108,170
3	EXEL	Exelixis, Inc.	460,585	$19,754,490
4	IONS	Ionis Pharmaceuticals Inc	252,250	$18,941,452
5	MRNA	Moderna, Inc. This page	368,421	$18,715,786
6	ARGX	Argenx SE	18,754	$13,695,108
7	RARE	Ultragenyx Pharmaceutical Inc.	613,229	$12,847,147
8	IOVA	Iovance Biotherapeutics, Inc.	3,486,299	$12,236,909

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$18,715,786	368,421	-30.7%	Shares	Defined	2026-05-14
2025-09-30	$13,735,929	531,782	+5.0%	Shares	Defined	2025-11-14
2024-12-31	$21,051,122	506,280	+831.1%	Shares	Defined	2025-02-14
2024-06-30	$6,457,150	54,376	+515.6%	Shares	Defined	2024-08-12
2023-06-30	$1,073,209	8,833	-90.2%	Shares	Defined	2023-08-11
2023-03-31	$13,867,198	90,293	+2820.2%	Shares	Defined	2023-05-12
2022-12-31	$555,385	3,092	-77.2%	Shares	Defined	2023-02-10
2021-12-31	$3,451,588	13,590	-97.7%	Shares	Defined	2022-02-14
2021-06-30	$140,052,544	596,019	+4244.5%	Shares	Defined	2021-08-16
2021-03-31	$1,796,503	13,719	-5.4%	Shares	Defined	2021-05-17
2020-09-30	$1,025,662	14,497	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.